DSKYF
:US OTC

Add to watchlist
$95.53
Last updated:09/18/2020
DSKYF: US OTC
$95.53
Daiichi Sankyo Co., Ltd.

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Dividend yield
-
P/E ratio
98.48x
Payout ratio
-
CASH payout ratio
-
Stock volatility (Beta)
past 12 months
Become our supporter to unlock all data!
Based on missed expected dividend payments we detected that dividend payouts might be suspended. Check the company website for further information.
DSKYF dividends
Create free account to unlock
Company results
Qtr
Ann
Fundamentals
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company profile
CEO
Sunao Manabe
Market capitalization
Mega (61.93B)